Sustained Complete Response to a Short Course of Subcutaneous Daratumumab in Multi-Refractory Immune Thrombocytopenia. (2026). Mediterranean Journal of Hematology and Infectious Diseases, 18(1), e2026069. https://doi.org/10.4084/MJHID.2026.069